Singapore’s healthcare system is generally efficient, delivering high-quality care while maintaining relatively low costs. In its World Health Report, the World Health Organization ranked Singapore’s system sixth worldwide. For the past two decades, Singapore has recorded the world’s lowest infant mortality rates. In 2019, Singaporeans had the highest life expectancy of any country, at 84.8 years. Women could expect to live an average of 87.6 years, including 75.8 years in good health; the corresponding averages for men were lower. Singapore ranked first on the Global Food Security Index.
As of December 2011 and January 2013, respectively, 8,800 foreigners and 5,400 Singaporeans had been diagnosed with HIV. However, annual HIV-related deaths remained below 10 per 100,000 people. Adult obesity affects fewer than 10% of the population, and immunisation coverage is high. In 2013, the Economist Intelligence Unit ranked Singapore as having Asia’s best quality of life and the world’s sixth-best overall.
The government’s healthcare system is built around the “3M” framework, comprising three elements: Medifund, a safety net for people unable to afford healthcare; Medisave, a compulsory national medical savings scheme that covers about 85% of the population; and Medishield, a government-funded health insurance programme. Singapore’s public hospitals have substantial autonomy over management and nominally compete for patients, although they remain government-owned. Low-income residents are eligible for subsidies. In 2008, the government funded 32% of healthcare expenditure. Healthcare represents approximately 3.5% of Singapore’s GDP.